Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis
Parasite, 5 3 (1998) 223-229
Published online: 2014-09-19
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
(2023)
https://doi.org/10.2139/ssrn.4571790
Metallic Nanoparticles and Core-Shell Nanosystems in the Treatment, Diagnosis, and Prevention of Parasitic Diseases
Grzegorz Król, Kamila Fortunka, Michał Majchrzak, Ewelina Piktel, Paulina Paprocka, Angelika Mańkowska, Agata Lesiak, Maciej Karasiński, Agnieszka Strzelecka, Bonita Durnaś and Robert BuckiPathogens 12 (6) 838 (2023)
https://doi.org/10.3390/pathogens12060838
The delayed death-causing nature of Rosmarinus officinalis leaf extracts and their mixture within experimental chronic toxoplasmosis: Therapeutic and prophylactic implications
Enas F. Abdel Hamed, Nahed E. Mostafa, Eman M. Fawzy, et al.Acta Tropica 221 105992 (2021)
https://doi.org/10.1016/j.actatropica.2021.105992
Repurposing auranofin for treatment of Experimental Cerebral Toxoplasmosis
Iman Fathy Abou-El-Naga and Nermine Mogahed Fawzy Hussein MogahedActa Parasitologica 66 (3) 827 (2021)
https://doi.org/10.1007/s11686-021-00337-z
In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii
Erica S. Martins-Duarte, Juliana de Araujo Portes, Ramon Borges da Silva, Hugo Silva Pires, Simon J. Garden and Wanderley de SouzaBioorganic & Medicinal Chemistry 50 116467 (2021)
https://doi.org/10.1016/j.bmc.2021.116467
Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation
Ana Carolina Moreira Souza, Andrea Grabe‐Guimarães, Jader dos Santos Cruz, Artur Santos‐Miranda, Charlotte Farah, Liliam Teixeira Oliveira, Alexandre Lucas, Franck Aimond, Pierre Sicard, Vanessa Carla Furtado Mosqueira and Sylvain RichardBritish Journal of Pharmacology 177 (19) 4448 (2020)
https://doi.org/10.1111/bph.15186
Toxoplasma gondii
Carsten G.K. Lüder, Utz Reichard and Uwe GroßToxoplasma gondii 321 (2020)
https://doi.org/10.1016/B978-0-12-815041-2.00007-4
Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis
Samuel D. ChorltonMedical Hypotheses 133 109376 (2019)
https://doi.org/10.1016/j.mehy.2019.109376
Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis
Samy Ibrahim El-Kowrany, Amira El-Sayed Abd El Ghaffar, Zeinab Salah Shoheib, Rasha Fadly Mady and Ghada Ahmed Moawad GameaActa Tropica 195 145 (2019)
https://doi.org/10.1016/j.actatropica.2019.04.013
Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review
Mahbobeh Montazeri, Saeed Mehrzadi, Mehdi Sharif, et al.Parasitology Research 117 (10) 3045 (2018)
https://doi.org/10.1007/s00436-018-6027-z
Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis
Sanaz Jafarpour Azami, Amir Amani, Hossein Keshavarz, et al.European Journal of Pharmaceutical Sciences 117 138 (2018)
https://doi.org/10.1016/j.ejps.2018.02.018
Nanomedicine advances in toxoplasmosis: diagnostic, treatment, and vaccine applications
João Paulo Assolini, Virginia Márcia Concato, Manoela Daiele Gonçalves, Amanda Cristina Machado Carloto, Ivete Conchon-Costa, Wander Rogério Pavanelli, Francine Nesello Melanda and Idessania Nazareth CostaParasitology Research 116 (6) 1603 (2017)
https://doi.org/10.1007/s00436-017-5458-2
Toxoplasmosis
Sprakel‐Leyke Silja, Paulke Bernd‐Reiner and Presber WolfgangToxoplasmosis (2017)
https://doi.org/10.5772/67156
Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases
Chad Curtis, Mengying Zhang, Rick Liao, Thomas Wood and Elizabeth NanceWIREs Nanomedicine and Nanobiotechnology 9 (2) (2017)
https://doi.org/10.1002/wnan.1422
Preventive prospective of triclosan and triclosan-liposomal nanoparticles against experimental infection with a cystogenic ME49 strain of Toxoplasma gondii
Lobna A. El-Zawawy, Doaa El-Said, Shereen F. Mossallam, Heba S. Ramadan and Salwa S. YounisActa Tropica 141 103 (2015)
https://doi.org/10.1016/j.actatropica.2014.09.020
Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis
Kenia Pissinate, Érica dos Santos Martins-Duarte, Scheila Rezende Schaffazick, et al.Parasitology Research 113 (2) 555 (2014)
https://doi.org/10.1007/s00436-013-3715-6
Toxoplasma Gondii
Carsten G.K. Lüder, Utz Reichard and Uwe GrossToxoplasma Gondii 217 (2014)
https://doi.org/10.1016/B978-0-12-396481-6.00007-6
Formulation and Characterization of Atovaquone Nanosuspension for Improved Oral Delivery in The Treatment of Malaria
Vivek Borhade, Sulabha Pathak, Shobhona Sharma and Vandana PatravaleNanomedicine 9 (5) 649 (2014)
https://doi.org/10.2217/nnm.13.61
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Florence Robert-Gangneux and Marie-Laure DardéClinical Microbiology Reviews 25 (2) 264 (2012)
https://doi.org/10.1128/CMR.05013-11
Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone
Javier Calvo, José Luis Lavandera, Maite Agüeros and Juan M. IracheBiomedical Microdevices 13 (6) 1015 (2011)
https://doi.org/10.1007/s10544-011-9571-1
Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo
Sandra Elisa Haas, Clarissa Cassini Bettoni, Laura Kausburg de Oliveira, Sílvia Stanisçuaski Guterres and Teresa Dalla CostaInternational Journal of Antimicrobial Agents 34 (2) 156 (2009)
https://doi.org/10.1016/j.ijantimicag.2009.02.024
The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis
Hend M. Shubar, Ildiko R. Dunay, Sabrina Lachenmaier, et al.Journal of Drug Targeting 17 (4) 257 (2009)
https://doi.org/10.1080/10611860902718680
Toxoplasma Gondii
U. Reichard and U. GrossToxoplasma Gondii 153 (2007)
https://doi.org/10.1016/B978-012369542-0/50009-X
Foodborne Parasites
Ynes R. OrtegaFood Microbiology And Food Safety Series, Foodborne Parasites 109 (2006)
https://doi.org/10.1007/0-387-31197-1_5
Polymeric Particulates to Improve Oral Bioavailability of Peptide Drugs
Florence Delie and María José Blanco-PríetoMolecules 10 (1) 65 (2005)
https://doi.org/10.3390/10010065
Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis
E. Cauchetier, M. Paul, D. Rivollet, et al.Annals of Tropical Medicine & Parasitology 97 (3) 259 (2003)
https://doi.org/10.1179/000349803235001840
Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis
Nadja Schöler, Karsten Krause, Oliver Kayser, et al.Antimicrobial Agents and Chemotherapy 45 (6) 1771 (2001)
https://doi.org/10.1128/AAC.45.6.1771-1779.2001
Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis
E. Cauchetier, M. Paul, D. Rivollet, et al.International Journal for Parasitology 30 (6) 777 (2000)
https://doi.org/10.1016/S0020-7519(00)00053-9
Congenital toxoplasmosis
F. DerouinCongenital toxoplasmosis 95 (2000)
https://doi.org/10.1007/978-2-8178-0847-5_7
LITERATURE ALERTS
Journal of Microencapsulation 16 (4) 535 (1999)https://doi.org/10.1080/026520499288997